Two-year outcome of warfarin monotherapy in HeartMate 3 left ventricular assist device: A single-center experience

J Heart Lung Transplant. 2020 Oct;39(10):1149-1151. doi: 10.1016/j.healun.2020.06.012. Epub 2020 Jul 24.

Authors

Hoong Sern Lim¹, Aaron Ranasinghe², Colin Chue¹, Jorge Mascaro²

Affiliations

¹ Department of Cardiology, University Hospitals Birmingham NHS Foundation Trust, Edgbaston, Birmingham, United Kingdom.
² Department of Cardiac Surgery, University Hospitals Birmingham NHS Foundation Trust, Edgbaston, Birmingham, United Kingdom.

PMID: 32739335
DOI: 10.1016/j.healun.2020.06.012

No abstract available

Publication types

Observational Study

MeSH terms

Anticoagulants / pharmacology
Female
Follow-Up Studies
Heart Failure / therapy*
Heart-Assist Devices / adverse effects*
Humans
Male
Middle Aged
Prosthesis Design
Retrospective Studies
Thrombosis / etiology
Thrombosis / prevention & control*
Time Factors
Warfarin / pharmacology*

Substances

Anticoagulants
Warfarin